You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華北製藥(600812.SH)擬向華藥集團發行股份及支付現金購買資產 明日復牌
格隆匯 04-16 20:57

格隆匯4月16日丨華北製藥(600812.SH)公佈,公司擬向華藥集團發行股份及支付現金購買華藥集團持有的愛諾公司51%股權(截至本預案摘要簽署日,華藥股份已持有愛諾公司49%股權)、動保公司100%股權及華藥集團持有的華北牌系列商標資產。

本次交易對價採取發行股份及支付現金相結合的方式,其中華藥集團持有的愛諾公司51%股權與動保公司100%股權全部通過發行股份支付對價,華藥集團持有的華北牌系列商標資產通過發行股份支付對價比例不低於50%,其餘部分以現金方式支付,具體比例將由交易雙方在補充協議中予以協商確定。

上市公司擬向不超過35名特定投資者非公開發行股份募集配套資金,發行股份數量不超過上市公司本次交易前總股本的30%,即不超過4.89億股,發行價格為7.28元/股。本次募集配套資金擬用於支付本次交易的現金對價、相關交易税費以及中介機構費用、補充上市公司和標的公司流動資金、償還債務等。

本次交易前,上市公司的主營業務為各類人用醫藥產品的研發、生產和銷售。本次交易完成後,愛諾公司、動保公司將成為上市公司的全資子公司,上市公司主營業務範圍拓展至人用藥、農藥、獸藥的研發、生產和銷售。愛諾公司、動保公司在農藥、獸藥業務領域耕耘多年,已在行業內具有一定品牌影響和競爭實力,同時農獸藥業務與人用醫藥業務在生產、研發、業務流程、管理經驗上存在相似之處。

通過本次交易,上市公司將持有華北牌系列商標,上市公司將加強對華北牌系列商標的管理,持續提升華北牌系列商標的品牌影響力,有利於進一步增強上市公司主營業務的市場競爭力,拓寬上市公司的業務範圍,做大做強農獸藥業務板塊,為上市公司培育新的業務增長點。

公司股票將於2020年4月17日開市起復牌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account